News

UK’s NICE issues final draft guidance recommending daratumumab plus bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is suitable

IrMn‑cluster‑based artificial metalloenzymes with radiosensitised systemic antitumour responses to prevent malignant tumour metastasis and recurrence

Response to neoadjuvant immunochemotherapy may allow for surgical de-escalation in head and neck cancers

Tumour cells: Disorder can promote spread

New MRI agent detects lung cancer, hidden metastases earlier than current scans

Triple-negative breast cancer: Methylglyoxal at the heart of immune evasion

Is stroke risk higher after a cancer diagnosis?

Helicobacter pylori exposure may be linked to more than 1 in 5 bowel cancer cases worldwide

Blood test could monitor bone metastasis in medullary thyroid cancer

Tiny tumour-triggered patches turn immune cells into cancer fighters

Scientists engineer ready-to-use cancer-fighting T cells for solid tumours

FDA grants accelerated approval to camizestrant with a CDK4/6 inhibitor for ESR1-Mutated HR-positive, HER2-negative locally advanced or metastatic breast cancer